Comparative study of different brands of stavudine capsules for the off-label 'opened capsule' dosing method recommended for HIV-infected infants and children in resource-limited settings

SAJCH South African Journal of Child Health

Volumn 3, Issue 2, 2009, Pages 44-47

  Innes, Steve ^a   Smuts, Marlize ^a   Cotton, Mark F ^a   Seifart, Heiner ^b   Rosenkranz, Bernd ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

'ASPEN'; GENERIC DRUG; STAVIR; STAVUDINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CAREGIVER; COMPARATIVE STUDY; CONTROLLED STUDY; DISPERSION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION;

EID: 75749111655     PISSN: 19943032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Meyers T, Eley B, Loening W. Guidelines for the Management of HIV-infected Children, National Department of Health, South Africa. 1st ed. Pinetown: Jacana Media Publishers, 2005: 82.
2. Package insert for BMS Zerit, Bristol-Myers Squibb Co, 2004.
3. Package insert for Aspen Stavudine, Aspen Pharmacare, 2006.
4. Medicines Control Council. Medicines Control Council Pharmaceutical and Analytical Guideline, no. 2.02: section 3.6.5. Pretoria: Medicines Control Council, 2004.
5. British Pharmacopoeia Commission. British Pharmacopoeia 2008. London: TSO (The Stationery Office), 2008.
6. American Academy of Pediatrics Policy Statement. Increasing antiretroviral drug access for children with HIV infection. Pediatrics 2007; 119 (4): 838-845.
7. WHO Paediatric Recommendations. HIV Treatment Bulletin 2007; 8 (1, 2). http://www.i-base.info/htb/v8/htb8-1-2/WHO.html (accessed 12 June 2009).
8. WHO HIV/AIDS Department. Applications for the 15th WHO model list of essential medicines. http://archives.who.int/eml/expcom/children/Comments/emlc/ HIV-WHO-comments.pdf (accessed 12 June 2009).
9. Pasquali SK, Hall M, Slonim AD, et al. Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease. Circ Cardiovasc Qual Outcomes 2008; 1: 74-83.